NSE · India · data to 2026-10-21
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO)
Glaxosmithkline Pharmaceuticals Ltd.: ₹2,495 on 2026-10-21. +9.9% a year since 2004, worst fall -47%. Year-by-year returns, risk profile and what followed its price patterns in the past.
Open the interactive chart and full historyKey numbers
| Last close | ₹2,495 |
| Return a year since 2004 | +9.9% |
| All-time high | ₹3,466 (2025-06-05) |
| Below its high | -28.0% |
| Worst fall | -47% (2008-01-31) |
| Yearly volatility | 26% |
| Beta vs its index | 0.28 |
| Risk / reward vs its market | Low risk · Low reward |
Returns by year
| Year | Return |
|---|---|
| 2026 | +0.9% |
| 2025 | +9.8% |
| 2024 | +18.6% |
| 2023 | +43.9% |
| 2022 | -24.9% |
| 2021 | +8.2% |
| 2020 | +0.8% |
| 2019 | +6.3% |
| 2018 | +21.7% |
| 2017 | -8.8% |
| 2016 | -17.6% |
| 2015 | +3.6% |
What followed its price patterns in the past
How often GLAXO was higher 40 trading days after each pattern, next to an ordinary day. History for learning, not a forecast.
| Pattern | Past cases | Higher after 40 days | On an ordinary day | Median move |
|---|---|---|---|---|
| Volume spike on an up day | 142 | 53% | 53% | +0.7% |
| Volume spike on a down day | 109 | 58% | 53% | +1.7% |
| Down streak | 87 | 55% | 53% | +1.1% |
| Big up day | 81 | 51% | 53% | +0.2% |
| Up streak | 69 | 49% | 53% | -0.6% |
| RSI rises above 70 | 66 | 52% | 53% | +1.0% |
| Big down day | 58 | 55% | 53% | +2.1% |
| RSI drops below 30 | 53 | 57% | 53% | +0.9% |
| Crosses above 200-day avg | 50 | 54% | 53% | +0.6% |
| Falls below 200-day avg | 50 | 56% | 53% | +1.3% |
| New 52-week high | 49 | 47% | 53% | -1.1% |
| Gap up | 35 | 57% | 53% | +1.8% |
ZOSH shows history and calculations for learning. It is not investment advice and does not tell anyone to buy or sell. Data: Yahoo Finance, AMFI, NSE and official sources; it can be late or wrong, so check before acting.